Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Control of Human PLP1 Expression Through Transcriptional Regulatory Elements and Alternatively Spliced Exons in Intron 1.
Orienting network dysfunction in progressive multiple sclerosis.
Registers of multiple sclerosis in Denmark.
A confusing case of multiple sclerosis and central nervous system graft versus host disease.
Deficiency in the mRNA export mediator Gle1 impairs Schwann cell development in the zebrafish embryo.
Demyelinating disorders secondary to TNF-inhibitor therapy for the treatment of psoriasis: A review.
Differentiation of neuromyelitis optica spectrum disorders from ultra-longitudinally extensive transverse myelitis in a cohort of Chinese patients.
Rapid parametric mapping of the longitudinal relaxation time t1 using two-dimensional variable flip angle magnetic resonance imaging at 1.5 tesla, 3 tesla, and 7 tesla.
Onset symptoms in paediatric multiple sclerosis.
Systemic Injection of Low-Dose Lipopolysaccharide Fails to Break down the Blood-Brain Barrier or Activate the TLR4-MyD88 Pathway in Neonatal Rat Brain.
Demyelination during multiple sclerosis is associated with combined activation of microglia/macrophages by IFN-γ and alpha B-crystallin.
Aquaporin-4 autoimmunity masquerading as a brainstem tumor.
CNS neuroimmunology seen by a neuropathologist.
Are Natalizumab and Fingolimod Analogous Second-Line Options for the Treatment of Relapsing-Remitting Multiple Sclerosis? A Clinical Practice Observational Study.
The Diagnosis and Treatment of Optic Neuritis.
Antibodies to aquaporin-1 are not present in neuromyelitis optica.
Potential role of 8-oxoguanine DNA glycosylase 1 as a STAT1 coactivator in endotoxin-induced inflammatory response.
A comparison between plasmapheresis and intravenous immunoglobulin in children with Guillain-Barré syndrome in Upper Egypt.
Loss of astrocytic leptin signaling worsens experimental autoimmune encephalomyelitis.
Incidence and prevalence of multiple sclerosis in Europe: a systematic review.
Consequences of perinatal bisphenol A exposure in a mouse model of multiple sclerosis.
Diffusion-weighted imaging and demyelinating diseases: new aspects of an old advanced sequence.
SIRT1 Activating compounds reduce oxidative stress mediated neuronal loss in viral induced CNS demyelinating disease.
Pain in experimental autoimmune encephalitis: a comparative study between different mouse models.
Multiple Sclerosis and the Iranian Revolution: Reply to the Comment by Magzhi et al..
Pages
« first
‹ previous
…
471
472
473
474
475
476
477
478
479
…
next ›
last »